Gillam M P, Bartolone L, Kopp P, Benvenga S
Division of Endocrinology, Metabolism, & Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Thyroid. 2005 Jul;15(7):734-41. doi: 10.1089/thy.2005.734.
The autosomal recessive Pendred's syndrome is defined by congenital sensorineural deafness, goiter, and impaired iodide organification. It is caused by mutations in the Pendred's syndrome (PDS) gene that encodes pendrin, a chloride/iodide transporter expressed in the thyroid, the inner ear, and the kidney. In this study we performed clinical and molecular analyses in three siblings from a nonconsanguineous Sicilian family who presented with the clinical features of Pendred's syndrome. PATIENTS AND MOLECULAR ANALYSES: In two sisters and one brother, the clinical diagnosis of Pendred's syndrome was established based on the findings of sensorineural hearing loss and large goiters. Thyroid function tests, perchlorate discharge tests, thyroid ultrasound, and scintigraphy were performed in all affected individuals. Exons 2 to 21 of the PDS gene were amplified by polymerase chain reaction (PCR) and both strands were submitted to direct sequence analysis.
The clinical diagnosis of Pendred's syndrome was supported by a positive perchlorate discharge test in the three afflicted siblings. Direct sequence analysis of the PDS gene revealed that all three harbored one allele with a novel mutation 890delC leading to a frameshift mutation and premature stop codon at position 302 (FS297 > 302X). On the other allele, two of the siblings had a previously described transition 1226G > A, which results in the substitution of arginine by histidine at position 409 (R409H). In the index patient, no mutation could be identified on the other allele. In functional studies, these mutants lose the ability of pendrin to mediate iodide efflux.
All three patients included in this study presented with the classic Pendred syndrome triad. Two siblings were compound heterozygous for mutations in the coding region of the PDS gene. The third individual could have an unidentified mutation in a regulatory or intronic region of the PDS gene, or an identical phenotype caused by distinct pathogenic mechanisms.
常染色体隐性遗传性彭德莱德综合征的特征为先天性感音神经性耳聋、甲状腺肿和碘有机化受损。它由彭德莱德综合征(PDS)基因突变引起,该基因编码pendrin,一种在甲状腺、内耳和肾脏中表达的氯化物/碘转运体。在本研究中,我们对一个非近亲结婚的西西里家庭的三名患有彭德莱德综合征临床特征的兄弟姐妹进行了临床和分子分析。
在两名姐妹和一名兄弟中,根据感音神经性听力损失和巨大甲状腺肿的检查结果确立了彭德莱德综合征的临床诊断。对所有受影响个体进行了甲状腺功能测试、高氯酸盐释放试验、甲状腺超声检查和闪烁扫描。通过聚合酶链反应(PCR)扩增PDS基因的第2至21外显子,并对两条链进行直接序列分析。
三名患病兄弟姐妹的高氯酸盐释放试验呈阳性,支持了彭德莱德综合征的临床诊断。PDS基因的直接序列分析显示,三人都携带一个等位基因,该等位基因有一个新的890delC突变,导致移码突变和第302位(FS297>302X)的过早终止密码子。在另一个等位基因上,两名兄弟姐妹有一个先前描述的1226G>A转换,导致第409位的精氨酸被组氨酸取代(R409H)。在索引患者中,另一个等位基因上未发现突变。在功能研究中,这些突变体失去了pendrin介导碘外流的能力。
本研究纳入的所有三名患者均表现出典型的彭德莱德综合征三联征。两名兄弟姐妹为PDS基因编码区突变的复合杂合子。第三名个体可能在PDS基因的调控或内含子区域存在未识别的突变,或者由不同致病机制导致相同的表型。